New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Siblings with unique genetic change help scientists progress drug search for type 1 diabetes April 18, 2024 UTA receives $1.1 million grant to train researchers in mathematical and computational methods for health December 7, 2023 DeepPBS: A geometric AI model for accurate prediction of protein-DNA binding specificity August 9, 2024
Siblings with unique genetic change help scientists progress drug search for type 1 diabetes April 18, 2024
UTA receives $1.1 million grant to train researchers in mathematical and computational methods for health December 7, 2023
DeepPBS: A geometric AI model for accurate prediction of protein-DNA binding specificity August 9, 2024